Pharmaceutical Technology on MSN10 小时
Eli Lilly pays $10m upfront for Organovo’s FXR agonist
Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...
Stoke Therapeutics, Inc. , a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine, today announced that management will present at the ...
BioCryst Pharmaceuticals stock climbs 9% on strong Orladeyo sales, 2025 revenue guidance boost, and market dominance. See why ...
One of Australia's biggest pathology providers reports that GP visits and pathology volumes remain well below the historical ...